Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
Clinical trial NCT06281964 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06281964
- Sponsor
- Avistone Biotechnology Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2028-06-30
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.